Literature DB >> 9398404

IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.

L A Rosenthal1, K D Winestock, D S Finbloom.   

Abstract

Despite differences in T cell responses induced by interleukin (IL)-2 and IL-7, both cytokines modulate T cell functions by activation of signal transducers and activators of transcription (STAT) proteins. We examined the contribution of the two isoforms of STAT5, STAT5A and STAT5B, to IL-2- and IL-7-induced activation of human peripheral blood T lymphoblasts. Both cytokines induced assembly of STAT5A and STAT5B containing complexes capable of binding to the interferon-gamma activation sequence (GAS), and these complexes rapidly translocated (within 1 min) into the nucleus of IL-2- or IL-7-treated cells. The kinetics of this translocation were delayed in IL-7-treated as compared to IL-2-treated cells. IL-2 and IL-7 were equivalent in their ability to induce tyrosine phosphorylation of STAT5A and STAT5B and to facilitate binding of these STATs to an immobilized GAS element. Both IL-2 and IL-7 induced substantial amounts of STAT5A/STAT5B heterodimerization. Moreover, we observed constitutive association of STAT3 with each STAT5 isomer. These data suggest that IL-2 and IL-7 induce assembly of STAT heterodimers in a similar manner and that subsequent cellular responses may be driven by induction of similar sets of genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398404     DOI: 10.1006/cimm.1997.1208

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  8 in total

1.  Effector CD8+ T cells recovered from an influenza pneumonia differentiate to a state of focused gene expression.

Authors:  Dana R Marshall; Elvia Olivas; Samita Andreansky; Nicole L La Gruta; Geoff A Neale; Astrid Gutierrez; David G Wichlan; Suzette Wingo; Cheng Cheng; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-14       Impact factor: 11.205

2.  T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors.

Authors:  Eric Krawczyk; Sergey N Zolov; Kevin Huang; Challice L Bonifant
Journal:  Cancer Immunol Res       Date:  2019-02-19       Impact factor: 11.151

3.  Interleukin-7, a new cytokine targeting the mouse hypothalamic arcuate nucleus: role in body weight and food intake regulation.

Authors:  Laurence Macia; Odile Viltart; Myriam Delacre; Christelle Sachot; Laurent Héliot; James P Di Santo; Isabelle Wolowczuk
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

4.  Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes.

Authors:  Odile Ducrey-Rundquist; Mireille Guyader; Didier Trono
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 5.  STAT heterodimers in immunity: A mixed message or a unique signal?

Authors:  Greg M Delgoffe; Dario A A Vignali
Journal:  JAKSTAT       Date:  2013-01-01

Review 6.  Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines.

Authors:  Connor J Dwyer; Hannah M Knochelmann; Aubrey S Smith; Megan M Wyatt; Guillermo O Rangel Rivera; Dimitrios C Arhontoulis; Eric Bartee; Zihai Li; Mark P Rubinstein; Chrystal M Paulos
Journal:  Front Immunol       Date:  2019-02-20       Impact factor: 7.561

7.  Voting-based cancer module identification by combining topological and data-driven properties.

Authors:  A K M Azad; Hyunju Lee
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Combined immunodeficiency evolving into predominant CD4+ lymphopenia caused by somatic chimerism in JAK3.

Authors:  Sol A Ban; Elisabeth Salzer; Martha M Eibl; Angela Linder; Christoph B Geier; Elisangela Santos-Valente; Wojciech Garncarz; Thomas Lion; Raphael Ott; Christoph Seelbach; Kaan Boztug; Hermann M Wolf
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.